Empirical cephalosporin treatment of melioidosis

Clinical Infectious Diseases

Volumn 28, Issue 6, 1999, Pages 1328-

  Chaowagul, Wipada ^a,b   Simpson, Andrew J H ^a,b,c   Suputtamongkol, Yupin ^a,b   White, Nicholas J ^a,b  

^a Sappasitthiprasong Hospital   (Thailand)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN; CLAVULANIC ACID; PENICILLIN G;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BURKHOLDERIA PSEUDOMALLEI; DRUG EFFICACY; DRUG INDICATION; ENDEMIC DISEASE; MELIOIDOSIS; PRIORITY JOURNAL;

EID: 0033055826     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/517787     Document Type: Article

References (5)

1. 1. Chaowagul W, White NJ, Dance DAB, et al. Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand. J Infect Dis 1989; 159:890 9.
2. 2. Suputtamongkol Y, Rajchanuwong A, Chaowagul W, et al. Ceftazidime vs. amoxicillin/clavulanate in the treatment of severe melioidosis. Clin Infect Dis 1994; 19:846-53.
3. 3. White NJ, Dance DAB, Chaowagul W, Wattanagoon Y, Wuthiekanun V, Pitakwatchara N. Halving of mortality of severe melioidosis by ceftazidime. Lancet 1989;ii:697-701.
4. 4. Dance DAB, Wuthiekanun V, Chaowagul W, White NJ. The antimicrobial susceptibility of Pseudomonas pseudomallei. Emergence of resistance in vitro and during treatment. J Antimicrob Chemother 1989;24:295-309.
5. 5. Ashdown LR, In vitro activities of the newer β-lactam and quinolone antimicrobial agents against Pseudomonas pseudomallei. Antimicrob Agents Chemother 1988;32:1435-6.